Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction

被引:23
作者
Gu, Xiaodong [1 ]
Huang, Ying [1 ]
Levison, Bruce S. [1 ]
Gerstenecker, Gary [3 ]
DiDonato, Anthony J. [1 ]
Hazen, Leah B. [1 ]
Lee, Joonsue [1 ]
Gogonea, Valentin [1 ,3 ]
DiDonato, Joseph A. [1 ]
Hazen, Stanley L. [1 ,2 ]
机构
[1] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Dept Cellular & Mol Med, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA
[3] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA
基金
美国国家卫生研究院;
关键词
CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; SERUM PARAOXONASE; LIPID-PEROXIDATION; CHOLESTEROL EFFLUX; PROTEOMIC ANALYSIS; LACTONASE ACTIVITY; PROTEIN; MYELOPEROXIDASE; HDL;
D O I
10.1074/jbc.M115.678334
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-associated protein with atherosclerosis-protective and systemic anti-oxidant functions. We recently showed that PON1, myeloperoxidase, and HDL bind to one another in vivo forming a functional ternary complex (Huang, Y., Wu, Z., Riwanto, M., Gao, S., Levison, B. S., Gu, X., Fu, X., Wagner, M. A., Besler, C., Gerstenecker, G., Zhang, R., Li, X. M., Didonato, A. J., Gogonea, V., Tang, W. H., et al. (2013) J. Clin. Invest. 123, 3815-3828). However, specific residues onPON1 involved in the HDL-PON1 interaction remain unclear. Unambiguous identification of protein residues involved in docking interactions to lipid surfaces poses considerable methodological challenges. Here we describe a new strategy that uses a novel synthetic photoactivatable and click chemistry-taggable phospholipid probe, which, when incorporated into HDL, was used to identify amino acid residues on PON1 that directly interact with the lipoprotein phospholipid surface. Several specific PON1 residues (Leu-9, Tyr-185, and Tyr-293) were identified through covalent crosslinks with the lipid probes using affinity isolation coupled to liquid chromatography with on-line tandem mass spectrometry. Based upon the crystal structure for PON1, the identified residues are all localized in relatively close proximity on the surface of PON1, defining a domain that binds to the HDL lipid surface. Site-specific mutagenesis of the identified PON1 residues (Leu-9, Tyr-185, and Tyr-293), coupled with functional studies, reveals their importance in PON1 binding to HDL and both PON1 catalytic activity and stability. Specifically, the residues identified on PON1 provide important structural insights into the PON1-HDL interaction. More generally, the new photoactivatable and affinity-tagged lipid probe developed herein should prove to be a valuable tool for identifying contact sites supporting protein interactions with lipid interfaces such as found on cell membranes or lipoproteins.
引用
收藏
页码:1890 / 1904
页数:15
相关论文
共 87 条
  • [1] Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization
    Aharoni, A
    Gaidukov, L
    Yagur, S
    Toker, L
    Silman, I
    Tawfik, DS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) : 482 - 487
  • [2] The HDL proteome in acute coronary syndromes shifts to an inflammatory profile
    Alwaili, Khalid
    Bailey, Dana
    Awan, Zuhier
    Bailey, Swneke D.
    Ruel, Isabelle
    Hafiane, Anouar
    Krimbou, Larbi
    Laboissiere, Sylvie
    Genest, Jacques
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2012, 1821 (03): : 405 - 415
  • [3] Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities
    Aviram, M
    Hardak, E
    Vaya, J
    Mahmood, S
    Milo, S
    Hoffman, A
    Billicke, S
    Draganov, D
    Rosenblat, M
    [J]. CIRCULATION, 2000, 101 (21) : 2510 - 2517
  • [4] Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase
    Aviram, M
    Rosenblat, M
    Bisgaier, CL
    Newton, RS
    Primo-Parmo, SL
    La Du, BN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) : 1581 - 1590
  • [5] Baker PW, 2000, J LIPID RES, V41, P1261
  • [6] Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
    Besler, Christian
    Heinrich, Kathrin
    Rohrer, Lucia
    Doerries, Carola
    Riwanto, Meliana
    Shih, Diana M.
    Chroni, Angeliki
    Yonekawa, Keiko
    Stein, Sokrates
    Schaefer, Nicola
    Mueller, Maja
    Akhmedov, Alexander
    Daniil, Georgios
    Manes, Costantina
    Templin, Christian
    Wyss, Christophe
    Maier, Willibald
    Tanner, Felix C.
    Matter, Christian M.
    Corti, Roberto
    Furlong, Clement
    Lusis, Aldons J.
    von Eckardstein, Arnold
    Fogelman, Alan M.
    Luescher, Thomas F.
    Landmesser, Ulf
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (07) : 2693 - 2708
  • [7] Exploiting Bioorthogonal Chemistry to Elucidate Protein-Lipid Binding Interactions and Other Biological Roles of Phospholipids
    Best, Michael D.
    Rowland, Meng M.
    Bostic, Heidi E.
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2011, 44 (09) : 686 - 698
  • [8] Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk
    Bhattacharyya, Tamali
    Nicholls, Stephen J.
    Topol, Eric J.
    Zhang, Renliang
    Yang, Xia
    Schmitt, David
    Fu, Xiaoming
    Shao, Mingyuan
    Brennan, Danielle M.
    Ellis, Stephen G.
    Brennan, Marie-Luise
    Allayee, Hooman
    Lusis, Aldons J.
    Hazen, Stanley L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (11): : 1265 - 1276
  • [9] Understanding high-density lipoprotein function in disease: Recent advances in proteomics unravel the complexity of its composition and biology
    Birner-Gruenberger, Ruth
    Schittmayer, Matthias
    Holzer, Michael
    Marsche, Gunther
    [J]. PROGRESS IN LIPID RESEARCH, 2014, 56 : 36 - 46
  • [10] BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911